BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 27938789)

  • 41. Colorectal polyps in ulcerative colitis and Crohn's colitis.
    Fort Gasia M; Ghosh S; Iacucci M
    Minerva Gastroenterol Dietol; 2015 Dec; 61(4):215-22. PubMed ID: 26446684
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Real-life chromoendoscopy for neoplasia detection and characterisation in long-standing IBD.
    Carballal S; Maisterra S; López-Serrano A; Gimeno-García AZ; Vera MI; Marín-Garbriel JC; Díaz-Tasende J; Márquez L; Álvarez MA; Hernández L; De Castro L; Gordillo J; Puig I; Vega P; Bustamante-Balén M; Acevedo J; Peñas B; López-Cerón M; Ricart E; Cuatrecasas M; Jimeno M; Pellisé M;
    Gut; 2018 Jan; 67(1):70-78. PubMed ID: 27612488
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A roadmap to the implementation of chromoendoscopy in inflammatory bowel disease colonoscopy surveillance practice.
    Sanduleanu S; Kaltenbach T; Barkun A; McCabe RP; Velayos F; Picco MF; Laine L; Soetikno R; McQuaid KR
    Gastrointest Endosc; 2016 Jan; 83(1):213-22. PubMed ID: 26364967
    [No Abstract]   [Full Text] [Related]  

  • 44. Multi-target stool DNA test in the surveillance of inflammatory bowel disease: a cross-sectional cohort study.
    Klepp P; Kisiel JB; Småstuen MC; Røseth A; Andersen SN; Vatn MH; Ahlquist DA; Moum BA; Brackmann S
    Scand J Gastroenterol; 2018 Mar; 53(3):273-278. PubMed ID: 29313389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Colorectal cancer: screening and surveillance in inflammatory bowel diseases - consensus of the working group for inflammatory bowel diseases of the Austrian Society of Gastroenterology and Hepatology].
    Angelberger S; Campregher C; Fuchssteiner H; Gasche C; Gröchenig HP; Haas T; Kazemi-Shirazi L; Mayer A; Miehsler W; Platzer R; Reinisch W; Steiner P; Tilg H; Tillinger W; Vogelsang H; Novacek G
    Z Gastroenterol; 2013 May; 51(5):450-7. PubMed ID: 23681899
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying the real-world challenges of dysplasia surveillance in inflammatory bowel disease: a retrospective cohort study in a tertiary health network.
    Elford AT; Hirsch R; McKay OM; Browne M; Moore GT; Bell S; Swan M
    Intern Med J; 2024 Jan; 54(1):96-103. PubMed ID: 37093665
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic Surveillance.
    Mooiweer E; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; van Bodegraven AA; Jansen JM; Mahmmod N; Kremer W; Siersema PD; Oldenburg B;
    Clin Gastroenterol Hepatol; 2015 Sep; 13(9):1656-61. PubMed ID: 25956835
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Colon cancer in inflammatory bowel disease: recent trends, questions and answers.
    Viennot S; Deleporte A; Moussata D; Nancey S; Flourié B; Reimund JM
    Gastroenterol Clin Biol; 2009 Jun; 33 Suppl 3():S190-201. PubMed ID: 20117342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.
    Marion JF; Waye JD; Israel Y; Present DH; Suprun M; Bodian C; Harpaz N; Chapman M; Itzkowitz S; Abreu MT; Ullman TA; McBride RB; Aisenberg J; Mayer L;
    Clin Gastroenterol Hepatol; 2016 May; 14(5):713-9. PubMed ID: 26656297
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Colorectal cancer in inflammatory bowel disease: a shift in risk?
    Gallinger ZR; Weizman AV
    Expert Rev Anticancer Ther; 2014 Jul; 14(7):847-56. PubMed ID: 24621115
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
    Itzkowitz SH; Harpaz N
    Gastroenterology; 2004 May; 126(6):1634-48. PubMed ID: 15168373
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Surveillance for dysplasia in patients with inflammatory bowel disease: an updated national survey of colonoscopic practice in New Zealand.
    Mullaney TG; McCombie A; Wakeman C; Eglinton T; Gearry R
    N Z Med J; 2020 Jun; 133(1517):56-65. PubMed ID: 32595221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A; Polyak S; Draganov PV
    World J Gastroenterol; 2009 Jan; 15(1):61-6. PubMed ID: 19115469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on Endoscopic Dysplasia Surveillance in Inflammatory Bowel Disease.
    Coelho-Prabhu N; Lewis JD
    Am J Gastroenterol; 2023 Oct; 118(10):1748-1755. PubMed ID: 37543741
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dysplasia detection rates under a surveillance program in a tertiary referral center for inflammatory bowel diseases: Real-world data.
    Snir Y; Ollech JE; Peleg N; Avni-Biron I; Eran-Banai H; Broitman Y; Sharar-Fischler T; Goren I; Levi Z; Dotan I; Yanai H
    Dig Liver Dis; 2024 Feb; 56(2):265-271. PubMed ID: 37858514
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Image-enhanced endoscopy is critical in the surveillance of patients with colonic IBD.
    Subramanian V; Bisschops R
    Gastrointest Endosc Clin N Am; 2014 Jul; 24(3):393-403. PubMed ID: 24975530
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M
    Dig Dis; 2010; 28(4-5):619-24. PubMed ID: 21088413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R; Caratto M; Caratto E; Caristo G; Fornaro F; Giovinazzo D; Sticchi C; Casaccia M; Andorno E
    Clin Colorectal Cancer; 2016 Sep; 15(3):204-12. PubMed ID: 27083409
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Advanced endoscopic techniques in the assessment of inflammatory bowel disease: new technology, new era.
    Iacucci M; Furfaro F; Matsumoto T; Uraoka T; Smith S; Ghosh S; Kiesslich R
    Gut; 2019 Mar; 68(3):562-572. PubMed ID: 30580249
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.